You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 99 No. 6, JUNE 1957 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Adrenocortical Function in Long-Term Treatment with Corticoids

R. G. LARZELERE, Jr., M.D.; E. A. BARTHOLD, M.D.; F. M. WILLETT, M.D.; T. V. FEICHTMEIR, M.D.; L. WILSON, M.D.; E. P. ENGLEMAN, M.D.

AMA Arch Intern Med. 1957;99(6):888-891.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It has been definitely established that the administration of cortisone results in suppression of adrenocortical function and atrophy of the adrenal cortex.1 These effects are believed to be due to suppression of secretion of corticotropin. The purposes of the current study were threefold: first, to determine the degree of adrenocortical responsiveness, if any, to the stimulus of exogenous corticotropin (ACTH) in pa- tients receiving continuous therapy with cortisone, hydrocortisone, and/or prednisone. (These three corticoids will be subsequently referred to simply as cortisone.)

The second purpose was to determine the influence, if any, of the daily dose of cortisone and/or the duration of therapy on the degree of adrenocortical response to corticotropin. The third purpose was to observe the change, if any, in responsiveness to corticotropin in persons who had been so tested twice before, and under identical conditions, while being maintained on long-term and continuous treatment with cortisone.2,3 . . . [Full Text PDF of this Article]


Author Affiliations

San Francisco

From the Medical Service, Veterans' Administration Hospital; University of California and Stanford University Schools of Medicine.


Footnotes

Submitted for publication Oct. 26, 1956.

Read at the Annual meeting of the American Rheumatism Association at Chicago, Ill., in June, 1956.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1957 American Medical Association. All Rights Reserved.